Skip to main content
All lobbying filings

BRACEWELL LLP

BRACEWELL LLP filed a Q2 report for AQUESTIVE THERAPEUTICS on July 16, 2026, reporting $60,000 in lobbying income.

Lobbying for AQUESTIVE THERAPEUTICS · pharmaceutical company

All filings by BRACEWELL LLP · Everything AQUESTIVE THERAPEUTICS has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 16, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
Indiana

Official filing document

 Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Consumer Issues/Safety/Products

CPSC issues related to packaging

Health Issues

Give Kids a Chance Act (H.R.1262),(S.932) and other issues related to therapeutics

 Bills named in this filing 2
  • H.R. 1262
    Mikaela Naylon Give Kids a Chance Act
  • S. 932
    Give Kids a Chance Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem